Valuation Strides Pharma Science Limited

Stocks

Market Closed - NSE India S.E. 07:07:21 2026-09-22 EDT			5-day change	1st Jan Change
1,217.40 ^INR	-1.43%		+2.87%	+35.21%

08-19	Strides Pharma Science Limited Receives USFDA Establishment Inspection Report for Bengaluru Facility	CI
08-12	Vintage Classic Limited and Ascent Capital Advisors India Private Limited acquired 65.05% stake in Pivot Path Private Limited from Strides Pharma Science Limited for INR 1.0 billion.	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	31,121	25,858	72,114	61,675	86,435	112,211	-
Change	-	-16.91%	178.88%	-14.47%	40.15%	29.82%	-
Enterprise Value (EV)	31,121	25,858	72,114	61,675	86,435	112,211	112,211
Change	-	-16.91%	178.88%	-14.47%	40.15%	29.82%	0%
P/E	-6.76x	-12.7x	-101x	1.71x	15.5x	17.9x	12.8x
PBR	1.32x	1.19x	3.39x	-	2.78x	3.03x	2.49x
PEG	-	0.2x	1.5x	-0x	-0.2x	1.4x	0.3x
Capitalization / Revenue	1.01x	0.7x	1.78x	1.35x	1.78x	1.93x	1.62x
EV / Revenue	0x	0x	0x	0x	0x	1.93x	1.62x
EV / EBITDA	-0x	0x	0x	0x	0x	10x	8.01x
EV / EBIT	-0x	0x	0x	-	0x	12.7x	10.3x
EV / FCF	-0x	-0x	0x	0x	0x	23.4x	17.1x
FCF Yield	-12.9%	-1.95%	8.08%	7.16%	3.29%	4.28%	5.85%
Dividend per Share ²	-	1.5	2.5	-	5	3	3
Rate of return	-	0.52%	0.32%	-	0.53%	0.25%	0.25%
EPS ²	-51.28	-22.49	-7.76	390.5	60.34	68.1	95.4
Distribution rate	-	-6.67%	-32.2%	-	8.29%	4.41%	3.14%
Net sales ¹	30,702	36,884	40,511	45,653	48,587	58,230	69,123
EBITDA ¹	-103.2	4,302	7,433	8,028	9,253	11,173	14,014
EBIT ¹	-2,531	1,869	5,226	-	7,229	8,850	10,940
Net income ¹	-4,602	-2,026	-706.1	35,935	5,562	6,277	8,798
Net Debt	-	-	-	-	-	-	-
Reference price ²	346.60	286.35	784.70	669.20	937.75	1,217.40	1,217.40
Nbr of stocks (in thousands)	89,790	90,303	91,900	92,163	92,173	92,173	-
Announcement Date	5/24/22	5/25/23	5/22/24	5/22/25	5/18/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
STRIDES PHARMA SCIENCE LIMITED	18.14x	-	-	0.24%	1.19B
SUN PHARMACEUTICAL INDUSTRIES LTD.	34.48x	6.47x	22.44x	0.91%	46.81B
OTSUKA HOLDINGS CO., LTD.	15.9x	1.97x	8.74x	1.7%	37.1B
ZYDUS LIFESCIENCES LIMITED	27.84x	3.97x	16.45x	0.58%	12.09B
CIPLA LIMITED	26.98x	3.27x	16.95x	0.94%	11.69B
KRKA, D. D.	18.58x	3.37x	11.75x	3.79%	9.03B
GEDEON RICHTER	9.49x	2.2x	5.69x	4.68%	7.45B
GLENMARK PHARMACEUTICALS LIMITED	29.8x	3.9x	18.14x	0.16%	7.22B
ONO PHARMACEUTICAL CO., LTD.	15.18x	2.01x	6.67x	3.28%	7.13B
Average	21.82x	3.39x	13.35x	1.81%	15.52B
Weighted average by Cap.	24.62x	3.98x	15.15x	1.56%